FDA gives thumbs up to Trump's budget proposal

14 February 2018
fda_big

The US Food and Drug Administration has issued an approving statement relating to President Donald Trump’s budget proposal, noting the inclusion of “about $400 million in additional funding,” which would in part “further promote innovation and competition.”

FDA Commissioner Scott Gottlieb said the initiatives in question would help advance drug and device competition and create more modern, US-based manufacturing, “including continuous manufacturing of drugs and biological products, including vaccines.”

The Commissioner provided a list of projects that the funding would, if approved, be used to support.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical